Article Text

Download PDFPDF
Prescribing for pregnancy: chronic skin diseases
  1. Deborah De Caux,
  2. Gayathri Mariappa,
  3. Gayathri Perera,
  4. Joanna Girling
  1. Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
  1. Correspondence to Dr Deborah De Caux, Chelsea and Westminster Hospital NHS Foundation Trust, London, SW10 9NH, UK; deborah.decaux{at}


Chronic skin disease is common in women of reproductive age. Although skin can improve or remain stable during pregnancy, it is also common for existing conditions to flare and for new conditions to develop. A small number of medications used to control chronic skin disease can potentially have adverse effects on the outcome of the pregnancy. This article forms part of a series on prescribing for pregnancy and highlights the importance of achieving good control of the skin disease prior to conception and during pregnancy. It emphasises the need for patient-centred, open and informed discussions around medication options to achieve good control. During pregnancy and breastfeeding each patient should be treated as an individual in accordance with the medications that are appropriate for them, their preferences, and the severity of their skin disease. This should be done through collaborative working across primary care, dermatology and obstetric services.

  • Breast feeding
  • Contraception
  • Pregnancy
  • Skin diseases
  • Evidence-Based Medicine

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

  • Provenance and peer review Commissioned; externally peer reviewed.